Abstract 2042P
Background
Breast cancer is the most diagnosed cancer affecting Australian women. While the incidence rate of breast cancer is lower in indigenous women than non-indigenous women the mortality rate is higher, with indigenous women 1.2 times more likely to die from the disease. The are many factors that contribute to this and if we want outcomes to improve for indigenous women with breast cancer, we must identify where practice and policy can change and improve. These findings may inform approaches for indigenous women in other high-income countries who experience similarly poor breast cancer outcomes.
Methods
This research employed the Context-Mechanism-Outcome (CMO) framework to reveal potential mechanisms and contextual factors that influence breast cancer outcomes for indigenous women. The framework explains generative causation, which helps to highlight the relationship between a context, mechanism, and outcome of a program or policy. The mechanisms and contextual factors were stratified into multiple levels; micro (interpersonal), meso (systemic), and macro (policy) levels. “If-Then-Because” statements were used to represent (broadly) the elements of CMO.
Results
The CMO framework allowed us to interpret evidence regarding indigenous women and breast cancer and provided nine practical ways to improve health outcomes and survival rates: 1. Improved health literacy regarding the importance of screening and early detection, delivered in a culturally safe way 2. Increased cultural safety and access to screening services 3. Presence of indigenous health service providers 4. Ensuring health service provider is local and/or familiar with indigenous culture and community 5. Culturally safe screening, diagnosis, treatment and follow-up settings 6. Local indigenous screening champions in the community 7. Protocols for abnormal results are tailored to local setting and community 8. Culturally safe support available for people who receive diagnoses 9. Policy is re-written in consultation with indigenous people and provides solutions to improve health outcomes.
Conclusions
Using the CMO framework, this study has provided nine practical measures to assist in improving the health outcomes for Australian indigenous women with breast cancer.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
V. Christie.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2086P - Management of opioids use disorder in cancer survivors
Presenter: Khalida Berkane
Session: Poster session 06
2087P - Impact of cancer pain on quality of life and financial well-being: A cross-sectional study on symptom management
Presenter: Raffaele Giusti
Session: Poster session 06
2088P - Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey among Italian oncologists
Presenter: Anna Amela Valsecchi
Session: Poster session 06
2090P - Management of trastuzumab deruxtecan-related nausea and vomiting in real-world practice
Presenter: Luca Licata
Session: Poster session 06
2091P - Dermocosmetics in management of cancer-related skin toxicities: International expert consensus highlighting the key role of oncology nurses
Presenter: Pascale Dielenseger
Session: Poster session 06
2092P - Bone loss in premenopausal Algerian women treated with chemotherapy for early-stage of breast cancer: Evaluation by DXA and identification of associated risk factors
Presenter: MACHEROUM Fatma zohra
Session: Poster session 06
2093P - Bioelectrical Impedance phase angle and obesity as a prognostic indicator in metastatic gastric cancer patients receiving second-line chemotherapy
Presenter: SangUk Han
Session: Poster session 06
2094P - A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for highly emetogenic chemotherapy in breast cancer
Presenter: Shinya Takada
Session: Poster session 06
2095P - Cancer rehabilitation program for cancer-related fatigue
Presenter: Aizhan Bekisheva
Session: Poster session 06